GT Biopharma, Inc. (GTBP)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
0. 33
+0.01
+3.1173%
$
3.67M Market Cap
- P/E Ratio
- Div Yield
366,399 Volume
-10.8 Eps
$ 0.32
Previous Close Want to track GTBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
GT Biopharma, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Dipen Mehta Invst LLC | 23,400 | $9,547.2 | $8,012.16 | -$1,535.04 | -16.08% |
 Richard Slavik Newbridge Financial Services Group Inc. | 3,750 | $9,504.5 | $1,282.87 | -$8,221.63 | -86.5% |
| CGL Chester Gary Lloyd Coston, McIsaac & Partners | 17,092 | $13,417.22 | $5,922.38 | -$7,494.84 | -55.86% |
 Vincent Incerto LaSalle St. Investment Advisors LLC | 11,000 | $4,488 | $3,843.4 | -$644.6 | -14.36% |
 Christopher C. Powers Farther Finance Advisors, LLC | 3,000 | $2,356 | $1,023 | -$1,333 | -56.58% |
 Alan Gilmore Private Wealth Management Group, LLC | 20,000 | $8,162 | $6,486 | -$1,676 | -20.53% |
 Kevyn Hill Hilltop National Bank | 100 | $41 | $34.1 | -$6.9 | -16.83% |
| RFA Reyes Financial Architecture Inc. Reyes Financial Architecture Inc. | 625 | $306 | $223.37 | -$82.63 | -27% |
